These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19254226)

  • 1. [Implantable cardioverters-defibrillators: prevention of sudden death].
    Bokeriia LA; Revishvili ASh; Neminushiĭ NM
    Kardiologiia; 2009; 49(2):84-9. PubMed ID: 19254226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable cardioverter-defibrillators in children.
    Blom NA
    Pacing Clin Electrophysiol; 2008 Feb; 31 Suppl 1():S32-4. PubMed ID: 18226032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical management and prevention of sudden cardiac death.
    Yousuf O; Chrispin J; Tomaselli GF; Berger RD
    Circ Res; 2015 Jun; 116(12):2020-40. PubMed ID: 26044254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [How many leads are needed for an ICD?].
    Schaumann A; Gödde M; Tönnis T
    Herz; 2005 Nov; 30(7):591-5. PubMed ID: 16333583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Implanted cardioverters-defibrillators in the treatment of arrhythmias and prevention of sudden death].
    Bokeriia LA; Revishvili ASh; Neminushchiĭ NM; Lomidze NN
    Ter Arkh; 2006; 78(10):76-80. PubMed ID: 17180945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Who should receive an implantable cardioverter-defibrillator after myocardial infarction?
    Mountantonakis S; Hutchinson MD
    Curr Heart Fail Rep; 2009 Dec; 6(4):236-44. PubMed ID: 19948092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten advances defining sudden cardiac death.
    Mitrani RD; Myerburg RJ
    Trends Cardiovasc Med; 2016 Jan; 26(1):23-33. PubMed ID: 25957808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
    Ding L; Hua W; Niu H; Chen K; Zhang S
    Europace; 2008 Sep; 10(9):1034-41. PubMed ID: 18559335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
    Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
    Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable device therapy.
    Goldenberg I; Moss AJ
    Prog Cardiovasc Dis; 2008; 50(6):449-74. PubMed ID: 18474287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life expectancy gains and cost-effectiveness of implantable cardioverter/defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    You JJ; Woo A; Ko DT; Cameron DA; Mihailovic A; Krahn M
    Am Heart J; 2007 Nov; 154(5):899-907. PubMed ID: 17967596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of antiarrhythmic drug therapy for the prevention of sudden cardiac death.
    Kamath GS; Mittal S
    Prog Cardiovasc Dis; 2008; 50(6):439-48. PubMed ID: 18474286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can we predict sudden cardiac death in long-term survivors of atrial switch surgery for transposition of the great arteries?
    Wheeler M; Grigg L; Zentner D
    Congenit Heart Dis; 2014; 9(4):326-32. PubMed ID: 24151816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive effectiveness of implantable cardioverter defibrillator in reducing sudden cardiac death in the Chinese population: a multicenter trial of ICD therapy versus non-ICD therapy.
    Hua W; Niu H; Fan X; Ding L; Xu YZ; Wang J; Chen K; Wang F; Zhang S;
    J Cardiovasc Electrophysiol; 2012 Nov; 23 Suppl 1():S5-9. PubMed ID: 23140347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials.
    Hess PL; Al-Khatib SM; Han JY; Edwards R; Bardy GH; Bigger JT; Buxton A; Cappato R; Dorian P; Hallstrom A; Kadish AH; Kudenchuk PJ; Lee KL; Mark DB; Moss AJ; Steinman R; Inoue LY; Sanders G
    Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2):179-86. PubMed ID: 25669833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sudden cardiac death in postmyocardial-infarction patients.
    Fahed J; Floyd KC; Tighe DA
    Panminerva Med; 2015 Jun; 57(2):71-86. PubMed ID: 25669163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator.
    Tanawuttiwat T; Garisto JD; Salow A; Glad JM; Szymkiewicz S; Saltzman HE; Kutalek SP; Carrillo RG
    Pacing Clin Electrophysiol; 2014 May; 37(5):562-8. PubMed ID: 24762055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy test of defibrillation in patients with cardiac resynchronization therapy with defibrillator CRT-D].
    Lubiński A
    Kardiol Pol; 2010 May; 68(5):519. PubMed ID: 20491011
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cardiac resynchronization therapy-always with ICD?].
    Stellbrink C
    Herz; 2005 Nov; 30(7):596-600. PubMed ID: 16333584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.